https://www.selleckchem.com/products/abt-199.html
Inv22 was detected in 17 out of the 79 samples. Additionally, CN-qPCR achieved clear separation for 10 female carriers and 10 non-Inv22 females, suggesting the assay may also be useful for molecular diagnosis of female carriers. CONCLUSIONS This new CN-qPCR method may provide a convenient and accurate F8 Inv22 test suitable for clinical use. © American Association for Clinical Chemistry 2020. All rights reserved. For permissions, please email [email protected] Point-of-care (POC) measurement of glucose is currently
Like
Comment
Share
